Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen Methodological Study in Osteoarthritis
NCT01231490Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing Naproxen with Placebo (2 arms). Primary endpoint: Change from baseline in the time to ascend and descend 11 stairs at Day 24. Started Sep 2008; status: completed.
02
Drugs
naproxen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01231490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231490.